...
首页> 外文期刊>Diagnostic microbiology and infectious disease >Feasibility of mitochondrial single nucleotide polymorphisms to detect and identify Aspergillus fumigatus in clinical samples
【24h】

Feasibility of mitochondrial single nucleotide polymorphisms to detect and identify Aspergillus fumigatus in clinical samples

机译:线粒体单核苷酸多态性检测和鉴定临床样品中烟曲霉的可行性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Invasive aspergillosis (IA) is a concerning fungal infection among immunocompromised patients due to the poor outcomes in its treatment related with the delay in an accurate diagnosis. Therefore, this study aimed to select informative mitochondrial single nucleotide polymorphism (SNP) markers suitable for detection and identification of Aspergillus fumigatus in clinical specimens. Four mitochondria( SNP markers were selected (Cox_488, CytB_246, Nad1_802, and NC_171) and tested on clinical and environmental strains of Fumigati and non-Fumigati Aspergillus species (n = 105). These markers were tested on clinical samples (n = 37) obtained from patients with aspergillosis. The Cox_488 SNP was detected in all clinical samples, whereas complete profiles detecting all 4 SNPs were only obtained from 6 samples (1 lung biopsy, 2 abscesses, and 3 bronchoalveolar lavages) from patients with a probable or proven Aspergillus infection. The mitSNApfu approach based on mitochondrial markers constitutes a new and promising diagnostic approach that was applied successfully on clinical specimens from patients with proven or probable IA. Nevertheless, the assay requires further optimization (in respect to extraction procedures) and clinical validation to allow its application in routine diagnostics. (C) 2014 Elsevier Inc. All rights reserved.
机译:侵袭性曲霉病(IA)是免疫力低下患者中令人关注的真菌感染,因为其治疗效果不佳与准确诊断的延迟有关。因此,本研究旨在选择信息量丰富的线粒体单核苷酸多态性(SNP)标记,以检测和鉴定临床标本中的烟曲霉。选择了四个线粒体(SNP标记)(Cox_488,CytB_246,Nad1_802和NC_171),并在烟曲霉和非烟曲霉属物种(n = 105)的临床和环境菌株中进行了测试,并在临床样品(n = 37)中进行了测试在所有临床样品中均检测到Cox_488 SNP,而仅从可能或已证实曲霉菌属患者的6个样品(1次肺活检,2个脓肿和3次支气管肺泡灌洗)中获得了检测所有4个SNP的完整概况。基于线粒体标志物的mitSNApfu方法构成了一种新的有前途的诊断方法,已成功应用于来自已证实或可能患有IA的患者的临床标本中,但该方法需要进一步优化(就提取程序而言)和临床验证才能(C)2014 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号